Table 1:
Correlation between epoxyeicosatrienoic acid (EET) concentrations and measures of body composition or steroids
| Measure | 14,15-EET | 11,12-EET | 8,9-EET | Total EETs | 14,15-DHET:(DHET+EET) |
|---|---|---|---|---|---|
| Body Weight |
ρ=−0.72 P=0.01 |
ρ=−0.52 P=0.12 |
ρ=−0.44 P=0.20 |
ρ=−0.66 P=0.030 |
ρ=−0.28 P=0.52 |
| Fat mass |
ρ=−0.67 P=0.028 |
ρ=−0.46 P=0.19 |
ρ=−0.45 P=0.20 |
ρ=−0.61 P=0.056 |
ρ=−0.45 P=0.20 |
| % Android Fat |
ρ=−0.6 P=0.057 |
ρ=−0.51 P=0.13 |
ρ=−0.55 P=0.099 |
ρ=−0.6 P=0.057 |
ρ=−0.67 P=0.028 |
| Corticosterone |
ρ=−0.11 P=0.83 |
ρ=−0.2 P=0.67 |
ρ=−0.24 P=0.59 |
ρ=−0.14 P=0.77 |
ρ=−0.1 P=0.85 |
| Cortisol |
ρ=−0.49 P=0.14 |
ρ=−0.53 P=0.11 |
ρ=−0.52 P=0.12 |
ρ=−0.54 P=0.10 |
ρ=−0.4 P=0.28 |
| MHigh-dose Insulin |
ρ=0.6 P=0.093 |
ρ=0.48 P=0.22 |
ρ=0.58 P=0.11 |
ρ=0.65 P=0.057 |
ρ=0.69 P=0.044 |
P-values are adjusted according to Benjamini and Hochberg. ρ indicates Spearman’s rank correlation ρ. ACTH indicates adrenocorticotropic hormone, and M indicates glucose infusion rate during high-dose insulin infusion, the primary measure of insulin sensitivity during hyperinsulinemic clamp.